402 related articles for article (PubMed ID: 9167107)
21. The Melbourne Pre-Diabetes Study: prediction of type 1 diabetes mellitus using antibody and metabolic testing.
Colman PG; McNair P; Margetts H; Schmidli RS; Werther GA; Alford FP; Ward GM; Tait BD; Honeyman MC; Harrison LC
Med J Aust; 1998 Jul; 169(2):81-4. PubMed ID: 9700342
[TBL] [Abstract][Full Text] [Related]
22. The Giessen-Bad Oeynhausen family study: improved prediction of type I diabetes in a low incidence population of relatives using combinations of islet autoantibodies in a dual step model.
Jaeger C; Hatziagelaki E; Stroedter A; Becker F; Scherer S; Petzoldt R; Federlin K; Bretzel RG
Exp Clin Endocrinol Diabetes; 1999; 107(8):496-505. PubMed ID: 10612480
[TBL] [Abstract][Full Text] [Related]
23. Autoantibodies to protein tyrosine phosphatase-like proteins in type I diabetes. Overlapping specificities to phogrin and ICA512/IA-2.
Kawasaki E; Eisenbarth GS; Wasmeier C; Hutton JC
Diabetes; 1996 Oct; 45(10):1344-9. PubMed ID: 8826969
[TBL] [Abstract][Full Text] [Related]
24. Postnatal elimination of transplacentally acquired disease-associated antibodies in infants born to families with type 1 diabetes. The Finnish TRIGR Study Group. Trial to Reduce IDDM in the Genetically at Risk.
Hämäläinen AM; Ronkainen MS; Akerblom HK; Knip M
J Clin Endocrinol Metab; 2000 Nov; 85(11):4249-53. PubMed ID: 11095462
[TBL] [Abstract][Full Text] [Related]
25. Identification of protein tyrosine phosphatase-like IA2 (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40K autoantigen and a target of islet-cell antibodies.
Bonifacio E; Lampasona V; Genovese S; Ferrari M; Bosi E
J Immunol; 1995 Dec; 155(11):5419-26. PubMed ID: 7594559
[TBL] [Abstract][Full Text] [Related]
26. High frequency of diabetes-specific autoantibodies in parents of children with type 1 diabetes. DENIS study group.
Seissler J; Atik Y; Klinghammer A; Scherbaum WA
Horm Metab Res; 1999 Dec; 31(12):657-61. PubMed ID: 10668918
[TBL] [Abstract][Full Text] [Related]
27. High T cell responses to the glutamic acid decarboxylase (GAD) isoform 67 reflect a hyperimmune state that precedes the onset of insulin-dependent diabetes.
Honeyman MC; Stone N; de Aizpurua H; Rowley MJ; Harrison LC
J Autoimmun; 1997 Apr; 10(2):165-73. PubMed ID: 9185878
[TBL] [Abstract][Full Text] [Related]
28. Autoantibodies associated with Type I diabetes mellitus persist after diagnosis in children.
Savola K; Sabbah E; Kulmala P; Vähäsalo P; Ilonen J; Knip M
Diabetologia; 1998 Nov; 41(11):1293-7. PubMed ID: 9833935
[TBL] [Abstract][Full Text] [Related]
29. [Islet autoantibody assays in type I diabetes: superiority of passage from use of ICA to traditional tests].
Lazar D; Weintrob N; Abramov N; Assa S; Bloch K; Ofan R; Ben-Zaken H; Vardi P
Harefuah; 1998 May; 134(9):678-81, 750. PubMed ID: 10909610
[TBL] [Abstract][Full Text] [Related]
30. [IA-2 and anti-GAD antibodies in patients with newly diagnosed type 1 diabetes and their first degree relatives].
Kretowski A; Kowalska I; Peczyńska J; Urban M; Kinalska I
Przegl Lek; 2000; 57(3):143-6. PubMed ID: 10909282
[TBL] [Abstract][Full Text] [Related]
31. Limited loss of tolerance to islet autoantigens in ICA+ first degree relatives of patients with type I diabetes expressing the HLA dqb1*0602 allele.
Gianani R; Verge CF; Moromisato-Gianani RI; Yu L; Zhang YJ; Pugliese A; Eisenbarth GS
J Autoimmun; 1996 Jun; 9(3):423-5. PubMed ID: 8816981
[TBL] [Abstract][Full Text] [Related]
32. [Evaluation of the importance of antibodies against islet cells (ICA) and Glutamate Decarboxylase(anti-GAD) for determining prognosis of diabetes type 1 in the Polish population--5 year observation].
Kretowski A; Szelachowska M; Kinalska I
Pol Arch Med Wewn; 1999 Apr; 101(4):323-7. PubMed ID: 10740410
[TBL] [Abstract][Full Text] [Related]
33. Antibodies to the protein tyrosine phosphatases IAR and IA-2 are associated with progression to insulin-dependent diabetes (IDDM) in first-degree relatives at-risk for IDDM.
Schmidli RS; Colman PG; Cui L; Yu WP; Kewming K; Jankulovski C; Harrison LC; Pallen CJ; DeAizpurua HJ
Autoimmunity; 1998; 28(1):15-23. PubMed ID: 9754810
[TBL] [Abstract][Full Text] [Related]
34. Associations of anti-GAD antibodies with islet cell antibodies and insulin autoantibodies in first-degree relatives of type I diabetic patients.
Roll U; Christie MR; Standl E; Ziegler AG
Diabetes; 1994 Jan; 43(1):154-60. PubMed ID: 8262311
[TBL] [Abstract][Full Text] [Related]
35. Islet autoantibodies in cord blood from children who developed type I (insulin-dependent) diabetes mellitus before 15 years of age.
Lindberg B; Ivarsson SA; Landin-Olsson M; Sundkvist G; Svanberg L; Lernmark A
Diabetologia; 1999 Feb; 42(2):181-7. PubMed ID: 10064098
[TBL] [Abstract][Full Text] [Related]
36. Combined analysis of islet cell antibodies which cross-react with mouse pancreas, antibodies to the M(r) 64,000 islet protein, and antibodies to glutamate decarboxylase in subjects at risk for IDDM.
Chaillous L; Delamaire M; Elmansour A; Maugendre D; Rohmer V; Joseph MG; Lecomte P; Limal JM; Charbonnel B; Allannic H
Diabetologia; 1994 May; 37(5):491-9. PubMed ID: 8056187
[TBL] [Abstract][Full Text] [Related]
37. IA-2-autoantibodies complement GAD65-autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings. The Belgian Diabetes Registry.
Gorus FK; Goubert P; Semakula C; Vandewalle CL; De Schepper J; Scheen A; Christie MR; Pipeleers DG
Diabetologia; 1997 Jan; 40(1):95-9. PubMed ID: 9028724
[TBL] [Abstract][Full Text] [Related]
38. Dynamics of Islet Autoantibodies During Prospective Follow-Up From Birth to Age 15 Years.
Pöllänen PM; Ryhänen SJ; Toppari J; Ilonen J; Vähäsalo P; Veijola R; Siljander H; Knip M
J Clin Endocrinol Metab; 2020 Dec; 105(12):e4638-51. PubMed ID: 32882033
[TBL] [Abstract][Full Text] [Related]
39. Islet cell autoimmunity in white and black children and adolescents with IDDM.
Libman IM; Pietropaolo M; Trucco M; Dorman JS; LaPorte RE; Becker D
Diabetes Care; 1998 Nov; 21(11):1824-7. PubMed ID: 9802728
[TBL] [Abstract][Full Text] [Related]
40. HLA-DQB1-defined genetic susceptibility, beta cell autoimmunity, and metabolic characteristics in familial and nonfamilial insulin-dependent diabetes mellitus. Childhood Diabetes in Finland (DiMe) Study Group.
Veijola R; Reijonen H; Vähäsalo P; Sabbah E; Kulmala P; Ilonen J; Akerblom HK; Knip M
J Clin Invest; 1996 Dec; 98(11):2489-95. PubMed ID: 8958211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]